Russell Wood, MD
Cardiac Surgery · Fayetteville, ARNPI 1366421653
Payments from drug & device makers
Across 595 payments — averaging $559.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$254K
- Medtronic$56K
- Edwards Lifesciences$5K
- Boston Scientific$4K
- Penumbra, Inc.$3K
- Abiomed$2K
- plus $9K from 24 others
What the payments were for
- Speaking & faculty fees$37,50042%
- Travel & lodging$24,72427%
- Food & beverage$27,77331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 77 | $254,494 |
| Medtronic(2 entities) | 333 | $55,620 |
| Edwards Lifesciences | 32 | $4,753 |
| Boston Scientific | 18 | $3,996 |
| Penumbra, Inc. | 18 | $3,370 |
| Abiomed | 14 | $1,746 |
| Abbott | 17 | $1,475 |
| Silk Road Medical, Inc. | 10 | $1,470 |
| Terumo Medical Corporation | 10 | $1,213 |
| Inari Medical, Inc. | 8 | $750 |
| Atricure, Inc. | 7 | $567 |
| Philips North America LLC | 9 | $522 |
| GE HealthCare | 4 | $447 |
| Cvrx, Inc. | 7 | $439 |
| Shockwave Medical, Inc | 3 | $431 |
| Davol Inc. | 8 | $382 |
| Livanova USA, Inc. | 2 | $235 |
| Cagent Vascular Inc | 1 | $140 |
| Bard Peripheral Vascular, Inc. | 1 | $121 |
| Stryker | 1 | $119 |
| W. L. Gore & Associates, Inc. | 2 | $111 |
| Getinge USA Sales, LLC | 3 | $110 |
| Kls-martin L.p. | 1 | $95 |
| Johnson & Johnson | 2 | $46 |
| Biom'up France SAS | 1 | $36 |
| KCI USA, Inc. | 2 | $34 |
| Novo Nordisk | 1 | $33 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| BD | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$42,007
- IN.PACT Admiral$7,212
- Alto Abdominal Stent Graft System$4,560
- ENDOCROSS Device$3,198
- Torus Stent Graft System$3,198
- EKOSONIC$2,616
- CoreValve Evolut$2,358
- Indigo System$2,202
- ENROUTE Transcarotid Neuroprotection System$1,442
- Impella$1,374
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,300
- ENHANCE Transcarotid Peripheral Access Kit$1,173
- ENROUTE Transcarotid Stent System$1,048
- ENROUTE 0.014 Guidewire$1,048
- Azur CX Detachable$934
- FLOWTRIEVER CATHETER, S$815
- Ovation$811
- ANGIOJET$738
- JETi Peripheral Catheter$669
- AFX2 Bifurcated Endograft System$609
How this compares
Too few cardiac surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 27 | $12,556 |
| XareltoRivaroxaban | 14 | $7,958 |
| Cilostazol | 107 | $1,378 |
| ClopidogrelClopidogrel Bisulfate | 152 | $763 |
| Atorvastatin Calcium | 41 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $46 | $7,95814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiac surgery providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other cardiac surgery in Fayetteville
- James CounceFayetteville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.